Hikma Pharmaceuticals PLC (GBP)
HIK
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Day Range20.10 | 20.40
52-Wk Range14.92 | 22.12
Last Close20.22
Mkt Cap (m)4,899.24
Dividend yield1.68%
ISINGB00B0LCW083
Volume267,054
Exchange VenueLON

Company Profile

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Key Information
Price/Earning16.89
Price/Book3.32
Price/Sales2.85
P/CF14.11
Rev Growth (3 year avg)12.86
EPS Growth (3 year avg)-0.02
Operating Margin % 18.26
Net Margin %13.62
Return on Equity17.63
Debt/Equity0.38

Legal Documents

Prospectus
en 22/01/2016
Annual Report
en 31/12/2018

Financials

Income Statement
GBP201320142015201620172018
Revenue (m)1,3651,4891,4401,9501,9362,070
Operating Income (m)352402417363323378
Net Income (m)212278252155-843282
Basic EPS1.081.401.270.67-3.511.17
Avg. Diluted Shares Outstanding (m)198200201234240242
Balance Sheet
GBP201320142015201620172018
Current Assets (m)8971,0131,3601,4481,5741,668
Non Current Assets (m)1,0321,2381,2372,9151,8141,829
Total Assets (m)1,9292,2512,5974,3633,3883,497
Current Liabilities (m)586841592918797893
Total Liabilities (m)------
Total Equity (m)1,0171,1971,3372,3961,5141,685
Cash Flows
GBP201320142015201620172018
Operating Cash Flows (m)337425366293443430
Capital Expenditure (m)-75-118-137-190-151-139
Figures are quoted in GBP unless stated otherwise
-0.04 (-0.18%)
£
20.18
Last Price